Literature DB >> 17140372

Diagnosis of pertussis: a historical review and recent developments.

Aaron Mark Wendelboe1, Annelies Van Rie.   

Abstract

The accurate and timely diagnosis of pertussis continues to be challenging. The widespread use of pertussis vaccines has dramatically altered the epidemiology and clinical presentation of pertussis disease, such that many cases do not present with the hallmark symptoms, such as inspiratory whoop, post-tussive vomiting and paroxysmal cough. A variety of laboratory tools are available to aid in the diagnosis of pertussis, including culture, direct fluorescent antibody testing, PCR, and paired and single serology techniques. This article reviews the strengths and limitations, including the sensitivity and specificity, of each of these diagnostic tools.

Entities:  

Mesh:

Year:  2006        PMID: 17140372     DOI: 10.1586/14737159.6.6.857

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  19 in total

1.  Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis.

Authors:  Andrew L Baughman; Kristine M Bisgard; Margaret M Cortese; William W Thompson; Gary N Sanden; Peter M Strebel
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

2.  Recent findings on pertussis epidemiology in Turkey.

Authors:  D Dilli; I Bostanci; Y Dallar; T Buzgan; H Irmak; M A Torunoğlu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

3.  Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Authors:  Sandra L Menzies; Vijay Kadwad; Lucia C Pawloski; Tsai-Lien Lin; Andrew L Baughman; Monte Martin; Maria Lucia C Tondella; Bruce D Meade
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

4.  Pertussis serodiagnosis in Belgium from 1990 to 2009.

Authors:  Muriel Vincent; Caroline Rodeghiero; Romain Eylenbosch; Yvan Mans; Jeannine Swalus-Steenhouwer; Denis Piérard; Kris Huygen; Raymond Vanhoof
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

5.  Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Authors:  Aditi Kapasi; Bruce D Meade; Brian Plikaytis; Lucia Pawloski; Monte D Martin; Sandra Yoder; Michael T Rock; Séverine Coddens; Valérie Haezebroeck; Françoise Fievet-Groyne; Garvin Bixler; Charles Jones; Stephen Hildreth; Kathryn M Edwards; Nancy E Messonnier; Maria L Tondella
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

6.  Abundance of the nasopharyngeal microbiome effects pertussis diagnosis and explains the sensitivity difference between bacterial culture and real-time PCR.

Authors:  Yijun Ding; Qing Wang; Dongfang Li; Kaihu Yao; Tianyou Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-03       Impact factor: 3.267

Review 7.  Clinically Diagnosing Pertussis-associated Cough in Adults and Children: CHEST Guideline and Expert Panel Report.

Authors:  Abigail Moore; Anthony Harnden; Cameron C Grant; Sheena Patel; Richard S Irwin
Journal:  Chest       Date:  2018-10-12       Impact factor: 9.410

8.  Bead-based polymerase chain reaction on a microchip.

Authors:  John P Hilton; ThaiHuu Nguyen; Mihaela Barbu; Renjun Pei; Milan Stojanovic; Qiao Lin
Journal:  Microfluid Nanofluidics       Date:  2012-05-16       Impact factor: 2.529

9.  Pertussis: not only a disease of childhood.

Authors:  Marion Riffelmann; Martina Littmann; Christel Hülße; Wiebke Hellenbrand; Carl Heinz Wirsing von König
Journal:  Dtsch Arztebl Int       Date:  2008-09-12       Impact factor: 5.594

10.  Using a bayesian latent class model to evaluate the utility of investigating persons with negative polymerase chain reaction results for pertussis.

Authors:  Gillian A M Tarr; Jens C Eickhoff; Ruth Koepke; Daniel J Hopfensperger; Jeffrey P Davis; James H Conway
Journal:  Am J Epidemiol       Date:  2013-06-04       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.